Literature DB >> 19064681

Diagnostic-therapeutic cascade revisited: coronary angiography, coronary artery bypass graft surgery, and percutaneous coronary intervention in the modern era.

F L Lucas1, A E Siewers, D J Malenka, D E Wennberg.   

Abstract

BACKGROUND: There is wide geographic variation in the use of coronary revascularization in the United States. Rates are closely related to rates of coronary angiography. We assessed the relationship between coronary angiography and coronary artery revascularization by procedure type (coronary artery bypass graft surgery or percutaneous coronary intervention). METHODS AND
RESULTS: Using Part B claims for a 20% sample of the Medicare population, we calculated population-based rates of testing and treatment by region, using events identified in Part B claims as the numerator and the total number of Medicare beneficiaries residing in the area as the denominator and adjusting for regional differences in demographic characteristics with the indirect method. Cardiac catheterization rates varied substantially across regions, from 16 to 77 per 1000 Medicare beneficiaries. The relationship between coronary angiography rates and total coronary revascularization rates was strong (R(2)=0.84). However, there was only a modest association between coronary angiography rates and coronary artery bypass graft surgery rates (R(2)=0.41) with the suggestion of a threshold effect. The association between coronary angiography rates and percutaneous coronary intervention rates was strong (R(2)=0.78) and linear.
CONCLUSIONS: The diagnostic-therapeutic cascade for coronary artery disease differs by therapeutic intervention. For coronary artery bypass graft surgery, the relationship is modest, and there appears to be a testing threshold beyond which additional tests do not result in additional surgeries. For percutaneous coronary intervention, the relationship is very tight, and no threshold appears to exist. Given the results of recent studies of medical versus invasive management of stable coronary disease, patients living in high-diagnostic-intensity regions may be getting more treatment than they want or need.

Entities:  

Mesh:

Year:  2008        PMID: 19064681      PMCID: PMC2706113          DOI: 10.1161/CIRCULATIONAHA.108.789446

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

1.  ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

Authors:  Kim A Eagle; Robert A Guyton; Ravin Davidoff; Fred H Edwards; Gordon A Ewy; Timothy J Gardner; James C Hart; Howard C Herrmann; L David Hillis; Adolph M Hutter; Bruce Whitney Lytle; Robert A Marlow; William C Nugent; Thomas A Orszulak; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Joseph P Ornato
Journal:  Circulation       Date:  2004-08-31       Impact factor: 29.690

2.  2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee.

Authors:  Spencer B King; Sidney C Smith; John W Hirshfeld; Alice K Jacobs; Douglass A Morrison; David O Williams; Ted E Feldman; Morton J Kern; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2007-12-13       Impact factor: 29.690

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  The impact of diagnostic testing on therapeutic interventions.

Authors:  D Verrilli; H G Welch
Journal:  JAMA       Date:  1996-04-17       Impact factor: 56.272

5.  Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease.

Authors:  M W Morgan; R B Deber; H A Llewellyn-Thomas; P Gladstone; R J Cusimano; K O'Rourke; G Tomlinson; A S Detsky
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

6.  Correlation of rates of coronary artery bypass surgery, angioplasty, and cardiac catheterization in 305 large communities for persons age 65 and older.

Authors:  E M Kuhn; A J Hartz; M Baras
Journal:  Health Serv Res       Date:  1995-08       Impact factor: 3.402

Review 7.  Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease.

Authors:  E J Topol; S E Nissen
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

8.  Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?

Authors:  W C Little; M Constantinescu; R J Applegate; M A Kutcher; M T Burrows; F R Kahl; W P Santamore
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

9.  Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease.

Authors:  Grace A Lin; R Adams Dudley; Rita F Redberg
Journal:  Arch Intern Med       Date:  2007 Aug 13-27

Review 10.  Coronary angioplasty for acute myocardial infarction.

Authors:  E J Topol
Journal:  Ann Intern Med       Date:  1988-12-15       Impact factor: 25.391

View more
  21 in total

1.  Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry.

Authors:  Steven M Bradley; John A Spertus; Kevin F Kennedy; Brahmajee K Nallamothu; Paul S Chan; Manesh R Patel; Chris L Bryson; David J Malenka; John S Rumsfeld
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

Review 2.  Clinical exome sequencing in neurologic disease.

Authors:  Brent L Fogel; Saty Satya-Murti; Bruce H Cohen
Journal:  Neurol Clin Pract       Date:  2016-04

3.  Downstream procedures and outcomes after stress testing for chest pain without known coronary artery disease in the United States.

Authors:  Daniel W Mudrick; Patricia A Cowper; Bimal R Shah; Manesh R Patel; Neil C Jensen; Eric D Peterson; Pamela S Douglas
Journal:  Am Heart J       Date:  2012-03       Impact factor: 4.749

Review 4.  Systematic review and cost-benefit analysis of radial artery access for coronary angiography and intervention.

Authors:  Matthew D Mitchell; Jaekyoung A Hong; Bruce Y Lee; Craig A Umscheid; Sarah M Bartsch; Creighton W Don
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-06-26

5.  Electrocardiograms in Low-Risk Patients Undergoing an Annual Health Examination.

Authors:  R Sacha Bhatia; Zachary Bouck; Noah M Ivers; Graham Mecredy; Jasjit Singh; Ciara Pendrith; Dennis T Ko; Danielle Martin; Harindra C Wijeysundera; Jack V Tu; Lynn Wilson; Kimberly Wintemute; Paul Dorian; Joshua Tepper; Peter C Austin; Richard H Glazier; Wendy Levinson
Journal:  JAMA Intern Med       Date:  2017-09-01       Impact factor: 21.873

6.  Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.

Authors:  John A Spertus; David J Maron; David J Cohen; Paul Kolm; Pam Hartigan; William S Weintraub; Daniel S Berman; Koon K Teo; Leslee J Shaw; Steven P Sedlis; Merril Knudtson; Mihaela Aslan; Marcin Dada; William E Boden; G B John Mancini
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-07-09

Review 7.  Understanding of regional variation in the use of surgery.

Authors:  John D Birkmeyer; Bradley N Reames; Peter McCulloch; Andrew J Carr; W Bruce Campbell; John E Wennberg
Journal:  Lancet       Date:  2013-09-28       Impact factor: 79.321

8.  Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative.

Authors:  Peter A Soden; Sara L Zettervall; Thomas Curran; Ageliki G Vouyouka; Philip P Goodney; Joseph L Mills; John W Hallett; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-09-28       Impact factor: 4.268

9.  Patterns of stress testing and diagnostic catheterization after coronary stenting in 250 350 medicare beneficiaries.

Authors:  Daniel W Mudrick; Bimal R Shah; Lisa A McCoy; Barbara L Lytle; Frederick A Masoudi; Jerome J Federspiel; Patricia A Cowper; Cynthia Green; Pamela S Douglas
Journal:  Circ Cardiovasc Imaging       Date:  2012-10-16       Impact factor: 7.792

10.  Hospital variation in the use of noninvasive cardiac imaging and its association with downstream testing, interventions, and outcomes.

Authors:  Kyan C Safavi; Shu-Xia Li; Kumar Dharmarajan; Arjun K Venkatesh; Kelly M Strait; Haiqun Lin; Timothy J Lowe; Reza Fazel; Brahmajee K Nallamothu; Harlan M Krumholz
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.